Hirsutism: A Guide for the Obstetrician and Gynecologist

    Srividya Sundararajan, Parivakkam S. Arunakumari, A. M. Skellett, Vijaya Srinivas
    TLDR Hirsutism is managed by assessing testosterone levels and using oral contraceptives, with ethical considerations on treatment access.
    The review provides a comprehensive guide for obstetricians and gynecologists on managing hirsutism, characterized by excess terminal hair in androgen-dependent areas in women. It highlights the Ferriman–Gallwey score as a tool for quantifying hirsutism and identifies polycystic ovary syndrome as the most common cause. The review emphasizes the importance of measuring total testosterone levels in patients with abnormal scores or clinical signs of hyperandrogenism. Hair reduction and removal methods are crucial in management, with combined oral contraceptives recommended as the first-line pharmacological treatment for those not seeking fertility. The review also discusses the ethical considerations of whether hirsutism treatment should be available on the NHS and if hair removal methods should be considered cosmetic or medical.
    Discuss this study in the Community →

    Research cited in this study

    9 / 9 results

    Related Community Posts Join

    6 / 30 results

      community I am having Success with RU58841 and 1mm Derma Roller

      in Microneedling  19 upvotes 4 years ago
      A user reported success with RU58841 and a 1mm derma roller for hair regrowth, noting significant improvement in hair density and reduced scalp visibility. They also mentioned using minoxidil and black castor oil in the past, with mixed results.

      community AA and Hirsutism but T levels are normal

      in Female  8 upvotes 5 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community Finasteride 5mg & Spironolactone 100mg

      in Female  2 upvotes 1 year ago
      A 20-year-old female is using finasteride 5mg and spironolactone 100mg for severe hirsutism and is experiencing minor side effects like water weight loss and irregular periods. She is concerned about potential future side effects and hair regrowth on her scalp.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  106 upvotes 4 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

    Similar Research

    5 / 1000+ results